Rituximab abrogates joint destruction in rheumatoid arthritis by inhibiting osteoclastogenesis. (2012)
Attributed to:
Centre for Musculoskeletal Ageing Research
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1136/annrheumdis-2011-200198
PubMed Identifier: 22072013
Publication URI: http://europepmc.org/abstract/MED/22072013
Type: Journal Article/Review
Volume: 71
Parent Publication: Annals of the rheumatic diseases
Issue: 1
ISSN: 0003-4967